Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016

Details for Mechanism ID: 16760
Country/Region: Eswatini
Year: 2014
Main Partner: University Research Corporation, LLC
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $1,375,000 Additional Pipeline Funding: N/A

NOTE: Narrative descriptions of programs were removed in COP2014. Limited summaries were released for some mechanisms on PEPFAR's Data Dashboard, but no description exists for this mechanism.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $100,000
Care: TB/HIV (HVTB) $865,887
Care: Pediatric Care and Support (PDCS) $50,000
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $100,000
Treatment: Adult Treatment (HTXS) $209,113
Treatment: Pediatric Treatment (PDTX) $50,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 4,691
C2.1.D By Age: 15+ 2015 65,610
C2.1.D By Age/Sex: <15 Female 2015 2,017
C2.1.D By Age/Sex: <15 Male 2015 2,675
C2.1.D By Age/Sex: 15+ Female 2015 35,734
C2.1.D By Age/Sex: 15+ Male 2015 29,874
C2.1.D By Sex: Female 2015 37,988
C2.1.D By Sex: Male 2015 32,313
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 70,301
C2.1.D Sum of Age disaggregates 2015 70,301
C2.1.D Sum of Age/Sex disaggregates 2015 70,300
C2.1.D Sum of Sex disaggregates 2015 70,301
C2.1.D_NA By Age: <15 2015 418
C2.1.D_NA By Age: 15+ 2015 5,973
C2.1.D_NA By Age/Sex: <15 Female 2015 174
C2.1.D_NA By Age/Sex: <15 Male 2015 242
C2.1.D_NA By Age/Sex: 15+ Female 2015 3,255
C2.1.D_NA By Age/Sex: 15+ Male 2015 2,720
C2.1.D_NA By Sex: Female 2015 2,894
C2.1.D_NA By Sex: Male 2015 3,497
C2.1.D_NA Number of HIV-positive individuals receiving a minimum of one clinical service 2015 6,391
C2.1.D_NA Sum of Age disaggregates 2015 6,391
C2.1.D_NA Sum of Age/Sex disaggregates 2015 6,391
C2.1.D_NA Sum of Sex disaggregates 2015 6,391
C2.1.D_NGI By Age: <15 2015 6,060
C2.1.D_NGI By Age: 15+ 2015 85,240
C2.1.D_NGI By Age/Sex: <15 Female 2015 2,590
C2.1.D_NGI By Age/Sex: <15 Male 2015 3,470
C2.1.D_NGI By Age/Sex: 15+ Female 2015 46,430
C2.1.D_NGI By Age/Sex: 15+ Male 2015 38,810
C2.1.D_NGI By Sex: Female 2015 49,020
C2.1.D_NGI By Sex: Male 2015 42,280
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 91,300
C2.1.D_NGI Sum of Age disaggregates 2015 91,300
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 91,300
C2.1.D_NGI Sum of Sex disaggregates 2015 91,300
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 91,300
CARE_NEW Age/sex: <1 Female 2015 20
CARE_NEW Age/sex: <1 Male 2015 20
CARE_NEW Age/sex: 1-4 Female 2015 137
CARE_NEW Age/sex: 1-4 Male 2015 101
CARE_NEW Age/sex: 10-14 Female 2015 61
CARE_NEW Age/sex: 10-14 Male 2015 60
CARE_NEW Age/sex: 15-19 Female 2015 141
CARE_NEW Age/sex: 15-19 Male 2015 121
CARE_NEW Age/sex: 20-24 Female 2015 282
CARE_NEW Age/sex: 20-24 Male 2015 171
CARE_NEW Age/sex: 25-49 Female 2015 1,815
CARE_NEW Age/sex: 25-49 Male 2015 2,128
CARE_NEW Age/sex: 5-9 Female 2015 61
CARE_NEW Age/sex: 5-9 Male 2015 61
CARE_NEW Age/sex: 50+ Female 2015 333
CARE_NEW Age/sex: 50+ Male 2015 539
CARE_NEW Aggregated Age/sex: <15 Female 2015 278
CARE_NEW Aggregated Age/sex: <15 Male 2015 242
CARE_NEW Aggregated Age/sex: 15+ Female 2015 2,571
CARE_NEW Aggregated Age/sex: 15+ Male 2015 2,959
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 6,050
CARE_NEW Sum of Age/sex disaggregates 2015 6,051
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 6,050
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 2
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 2
CARE_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 23
CARE_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR supported sites providing clinical care services 2015 25
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 25
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 25
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 27
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 27
QI_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 8
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 8
QI_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 52
QI_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 52
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 60
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 60
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 60
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 60
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: Care and Support Technical Assistance-only (TA) 2015 76
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 8
SITE_SUPP By program area/support type: TB/HIV Technical Assistance-only (TA) 2015 53
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: Treatment Technical Assistance-only (TA) 2015 53
TB_ART Age: 0-4 2015 135
TB_ART Age: 15+ 2015 2,457
TB_ART Age: 5-14 2015 108
TB_ART Aggregated Age: <15 2015 243
TB_ART Aggregated Age: 15+ 2015 2,457
TB_ART Female 2015 1,269
TB_ART Known HIV-positive 2015 2,100
TB_ART Male 2015 1,431
TB_ART Newly tested 2015 900
TB_ART Sum of Aggregated Age disaggregates 2015 2,700
TB_ART Sum of Sex disaggregates 2015 2,700
TB_ART Sum of Test Status disaggregates 2015 3,000
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 3,000
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 2,700
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 8
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 6
TB_ARTSITE By site support type: Technical Assistance-only (TA): The number of PEPFAR-supported TB basic management units 2015 48
TB_ARTSITE By site support type: Technical Assistance-only (TA): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 40
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 46
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 86
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 86
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 56
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 91,300
TX_CURR Age/Sex: <1 Female 2015 3
TX_CURR Age/Sex: <1 Female 2015 3
TX_CURR Age/Sex: <1 Male 2015 3
TX_CURR Age/Sex: <1 Male 2015 3
TX_CURR Age/Sex: 1-4 Female 2015 29
TX_CURR Age/Sex: 1-4 Female 2015 13
TX_CURR Age/Sex: 1-4 Male 2015 21
TX_CURR Age/Sex: 1-4 Male 2015 11
TX_CURR Age/Sex: 15+ Female 2015 997
TX_CURR Age/Sex: 15+ Female 2015 268
TX_CURR Age/Sex: 15+ Male 2015 991
TX_CURR Age/Sex: 15+ Male 2015 278
TX_CURR Age/Sex: 5-14 Female 2015 44
TX_CURR Age/Sex: 5-14 Female 2015 12
TX_CURR Age/Sex: 5-14 Male 2015 37
TX_CURR Age/Sex: 5-14 Male 2015 12
TX_CURR Aggregated Age/Sex: <1 Female 2015 3
TX_CURR Aggregated Age/Sex: <1 Female 2015 3
TX_CURR Aggregated Age/Sex: <1 Male 2015 3
TX_CURR Aggregated Age/Sex: <1 Male 2015 3
TX_CURR Aggregated Age/Sex: <15 Female 2015 76
TX_CURR Aggregated Age/Sex: <15 Female 2015 28
TX_CURR Aggregated Age/Sex: <15 Male 2015 61
TX_CURR Aggregated Age/Sex: <15 Male 2015 26
TX_CURR Aggregated Age/Sex: 15+ Female 2015 997
TX_CURR Aggregated Age/Sex: 15+ Female 2015 268
TX_CURR Aggregated Age/Sex: 15+ Male 2015 991
TX_CURR Aggregated Age/Sex: 15+ Male 2015 278
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 2,125
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 600
TX_CURR Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 5
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 49
TX_CURR Sum of age/sex disaggregates 2015 54
TX_CURR Sum of Age/Sex disaggregations 2015 137
TX_CURR Sum of Aggregated Age/Sex <15 2015 137
TX_CURR Sum of Aggregated Age/Sex <15 2015 54
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 1,988
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 546
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 2,125
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 600
TX_CURR_NGI Age/Sex: <1 Female 2015 5
TX_CURR_NGI Age/Sex: <1 Male 2015 4
TX_CURR_NGI Age/Sex: 1-4 Female 2015 34
TX_CURR_NGI Age/Sex: 1-4 Male 2015 25
TX_CURR_NGI Age/Sex: 15+ Female 2015 1,387
TX_CURR_NGI Age/Sex: 15+ Male 2015 1,416
TX_CURR_NGI Age/Sex: 5-14 Female 2015 54
TX_CURR_NGI Age/Sex: 5-14 Male 2015 49
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 5
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 4
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 93
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 78
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 1,387
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 1,416
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 2,974
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 2,974
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 171
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 2,803
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 2,974
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 4
TX_DIST Total number of PEPFAR supported District Health Offices 2015 4
TX_NEW Aggregated Grouping by Age: <1 Male 2015 2
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 3
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 46
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 43
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 400
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 450
TX_NEW By Age/Sex: <1 Female 2015 3
TX_NEW By Age/Sex: <1 Male 2015 2
TX_NEW By Age/Sex: 1-4 Female 2015 22
TX_NEW By Age/Sex: 1-4 Male 2015 20
TX_NEW By Age/Sex: 10-14 Female 2015 9
TX_NEW By Age/Sex: 10-14 Male 2015 9
TX_NEW By Age/Sex: 15-19 Female 2015 26
TX_NEW By Age/Sex: 15-19 Male 2015 17
TX_NEW By Age/Sex: 20-24 Female 2015 40
TX_NEW By Age/Sex: 20-24 Male 2015 30
TX_NEW By Age/Sex: 25-49 Female 2015 337
TX_NEW By Age/Sex: 25-49 Male 2015 272
TX_NEW By Age/Sex: 5-9 Female 2015 10
TX_NEW By Age/Sex: 5-9 Male 2015 10
TX_NEW By Age/Sex: 50+ Female 2015 49
TX_NEW By Age/Sex: 50+ Male 2015 83
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 939
TX_NEW Sum of Age/Sex disaggregates 2015 939
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 939
Cross Cutting Budget Categories and Known Amounts Total: $163,870
Human Resources for Health $150,000
Renovation $13,870
Key Issues Identified in Mechanism
Child Survival Activities
Military Populations
Mobile Populations
Safe Motherhood
Tuberculosis
Workplace Programs
End-of-Program Evaluation